Taipei, Taiwan

Hui Ju Liang

USPTO Granted Patents = 2 


Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Innovations by Inventor Hui Ju Liang in Virology and Allergy Treatment

Introduction

Hui Ju Liang is a prominent inventor based in Taipei, Taiwan, recognized for his innovative contributions to the fields of virology and allergy treatment. With a total of two patents, he has made significant strides in developing medicaments that address urgent health concerns.

Latest Patents

His latest patents include a groundbreaking "Method and composition for inhibiting virus infection," which focuses on creating a composition for preparing a medicament aimed at preventing and treating virus infections, particularly hepatitis B and herpes simplex viruses. The second patent is titled "Method for treating an allergic disease." This invention highlights the utilization of compounds such as ovatodiolide, 1'-acetoxychavicol acetate, and zerumbone for manufacturing a medicament addressing allergic diseases. Furthermore, it provides a method and a composition for effectively treating such conditions.

Career Highlights

Hui Ju Liang works at Arjil Biotech Holding Company Limited, a company that is committed to advancing biotechnological innovations. His work contributes to the company's mission of developing effective health solutions through innovative research and development.

Collaborations

Throughout his career, Hui Ju Liang has collaborated with esteemed colleagues such as Yeh B Wu and Jir-Mehng Lo. Their teamwork has facilitated a dynamic research environment, enhancing the quality and impact of their innovations.

Conclusion

Hui Ju Liang has established himself as a key figure in the invention of medical solutions for viral and allergic diseases. His contributions are pivotal in the pursuit of advancements in healthcare, making a positive impact on public health and medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…